Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2059]

SABCS congress news: Chemotherapy plus sorafenib 'offers breast cancer patients improvement in response rate'

SABCS congress news: Chemotherapy plus sorafenib 'offers breast cancer patients improvement in response rate'

SABCS congress news: Promising results from 'Notch' pathway inhibitor tests

SABCS congress news: Promising results from 'Notch' pathway inhibitor tests

SABCS congress news: Exemestane taken as initial endocrine therapy 'will improve relapse-free survival'

SABCS congress news: Exemestane taken as initial endocrine therapy 'will improve relapse-free survival'

SABCS congress news: 'Use of bisphosphonates' reduces risk of postmenopausal breast cancer

SABCS congress news: 'Use of bisphosphonates' reduces risk of postmenopausal breast cancer

SABCS congress news: Fewer invasive breast cancers for bisphosphonate users

SABCS congress news: Fewer invasive breast cancers for bisphosphonate users

SABCS congress news: Zoledronic acid 'safe and effective' in preventing bone loss

SABCS congress news: Zoledronic acid 'safe and effective' in preventing bone loss

ASH congress news: Emerging therapies for multiple myeloma

ASH congress news: Emerging therapies for multiple myeloma

ASH congress news: Bendamustine plus rituximab for treatment of advanced follicular, indolent, and mantle cell lymphomas

ASH congress news: Bendamustine plus rituximab for treatment of advanced follicular, indolent, and mantle cell...

No change in brain tumour incidence during a time when cell phone usage increased

No change in brain tumour incidence during a time when cell phone usage increased

Steady decline in European cancer mortality

Steady decline in European cancer mortality

More from ecancer